People with autism four times at risk of developing Parkinson’s disease
HQ Team May 31, 2025: Autism and Parkinson’s disease share underlying biological mechanisms, and people with an autism diagnosis are four times more.
Health
Medical
Research
Drugs
Health
Research
Scientists make gene ‘truck’ to unload genetic package in brain, spine
HQ Team May 30, 2025: Stanford University, along with other researchers, has developed a set of gene delivery systems that can reach different.
Drugs
Health
Research
New Parkinson’s test to detect disease even before symptoms appear
HQ Team May 5, 2025: Scientists have developed a test by studying how an abnormally-shaped protein in the spinal fluid can detect 90%.
Drugs
Health
Research
Stem cell therapy revives hope for patients with Parkinson’s disease
HQ Team April 17, 2025: Stem cell therapies, which replace dead cells in the brain, can stop movement problems, rigidity and tremors in.
Health
Research
Scientists unveil PINK1 protein structure, paving way for Parkinson’s Disease therapies
HQ Team March 20, 2025: Scientists at the Walter and Eliza Hall Institute (WEHI, Australia) have uncovered the structure of the PINK1 protein.
Drugs
Research
Celon Pharma’s pill shows promise in reducing dyskinesia in Parkinson’s trial
HQ Team March 17, 2025: Celon Pharma’s human trial with PDE10A inhibitor, CPL’36, has achieved statistically significant reductions in involuntary movements caused by.
Health
Research
MIT’s 40Hz gamma stimulation shows promise in slowing Alzheimer’s progression
HQ Team March 15, 2025: A decade of research at MIT’s Picower Institute for Learning and Memory has brought hope to millions battling.
Health
Research
Parkinson’s Disease cases to hit 25 million worldwide by 2050
HQ Team March 10, 2025: A recent study published in The BMJ forecasts a significant rise in Parkinson’s disease cases globally, with projections.
Health
Medical
Pharma
Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval
Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.
Drugs
Health
Medical
Supernus’ injection to treat advanced Parkinson’s gets US regulator’s nod
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.